Parallel Bio
Biotechnology ResearchMassachusetts, United States2-10 Employees
Parallel Bio created a human 'immune system in a dish' to discover drugs and immunotherapies more likely to work in patients.
Cutting-Edge Technology Parallel Bio utilizes a sophisticated tech stack including Python and Google Hosted Libraries to create innovative solutions in biotechnology research, positioning them as a leader in leveraging technology to drive scientific advancements.
Immune System Innovation By developing a human 'immune system in a dish,' Parallel Bio offers a unique approach to drug discovery and immunotherapy development, presenting an opportunity for collaboration with research institutions and pharmaceutical companies seeking groundbreaking methodologies.
Strategic Location Based in the biotech hub of Cambridge, Massachusetts, Parallel Bio benefits from a rich ecosystem of research institutions, potential partners, and investors, making them a prime target for local collaborations and industry networking events.
Funding & Growth Potential With a recent funding round of $4.3M and revenue potential of $0 - 10M, Parallel Bio demonstrates financial stability and growth prospects, making them an attractive target for strategic partnerships, investment opportunities, and joint ventures.
Niche Market Differentiation Within the competitive landscape of biotechnology research, Parallel Bio's focus on creating a human 'immune system in a dish' sets them apart, offering a niche expertise that can be leveraged to target clients looking for specialized solutions in drug development and personalized medicine.
Parallel Bio uses 8 technology products and services including Google Hosted Libraries, Squarespace Commerce, Stimulus, and more. Explore Parallel Bio's tech stack below.
Parallel Bio Email Formats | Percentage |
First.Last@parallel.bio | 33% |
First@parallel.bio | 17% |
First.Last@parallel.bio | 33% |
First@parallel.bio | 17% |
Biotechnology ResearchMassachusetts, United States2-10 Employees
Parallel Bio created a human 'immune system in a dish' to discover drugs and immunotherapies more likely to work in patients.
Parallel Bio has raised a total of $4.3M of funding over 2 rounds. Their latest funding round was raised on Dec 20, 2022 in the amount of $4.3M.
Parallel Bio's revenue is in the range of $10M
Parallel Bio has raised a total of $4.3M of funding over 2 rounds. Their latest funding round was raised on Dec 20, 2022 in the amount of $4.3M.
Parallel Bio's revenue is in the range of $10M